2017
DOI: 10.1016/j.cjca.2017.04.015
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Features, Diagnosis, and Management of Patients With Anderson-Fabry Cardiomyopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
29
0
4

Year Published

2017
2017
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 39 publications
(34 citation statements)
references
References 135 publications
1
29
0
4
Order By: Relevance
“…Accelerated vascular disease with progressive renal failure, cardiomyopathy and occlusive cerebro-vascular events are associated with early mortality in subjects with Fabry disease 26 . Whilst some clinical and experimental studies have shown that accumulation of globotriaosylceramide in endothelial cells may contribute to vascular dysfunction 27 , 28 , others have not 29 . Additionally, activation of innate immunity via dendritic cells has been associated with renal and cardiac inflammation in Fabry disease 30 32 .…”
Section: Introductionmentioning
confidence: 99%
“…Accelerated vascular disease with progressive renal failure, cardiomyopathy and occlusive cerebro-vascular events are associated with early mortality in subjects with Fabry disease 26 . Whilst some clinical and experimental studies have shown that accumulation of globotriaosylceramide in endothelial cells may contribute to vascular dysfunction 27 , 28 , others have not 29 . Additionally, activation of innate immunity via dendritic cells has been associated with renal and cardiac inflammation in Fabry disease 30 32 .…”
Section: Introductionmentioning
confidence: 99%
“…In those with atrial fibrillation (AF), no established disease-specific guidelines are present, but in general, the threshold for anticoagulation is lower even with short paroxysms of AF given the increased risk of thromboembolism in the setting of structural or valvular heart disease (January et al 2014 ; Yogasundaram et al 2017 ). Antiarrhythmics such as sotalol or amiodarone may be used in Fabry patients although general principles of avoiding bradycardia and care with QTc prolongation are necessary.…”
Section: Treatment Of Cardiac Disease In Afdmentioning
confidence: 99%
“…The accumulation of glycosphingolipids, mainly globotriaosylceramide (Gb3), involves all cardiac tissues, including cardiomyocytes, vessels, cardiac valves, nerves and conduction system 6 . The ventricular hypertrophy in FD is usually concentric and frequently involves the right ventricle 7 .…”
Section: Pathological Differential Diagnosis Of Hcmmentioning
confidence: 99%